Raily Aesthetic Medicine International Holdings Limited provided earnings guidance for the year ended 31 December 2023. For the year, the Group expects record: a revenue of approximately RMB189 million for the year ended 31 December 2023 (2022: revenue of approximately RMB 165 million); and a loss attributable to owners of the parent of approximately RMB 32 million for the year ended 31 December 2023 (2022: loss attributable to owners of the parent of approximately RMB16 million).